Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bio Fund Iv, L.p. Ah currently holds 10,232,420 shares of Braveheart Bio, Inc. (BRVE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bio Fund Iv, L.p. Ah has been a net buyer of BRVE stock. They have purchased $19.8M and sold $0 worth of shares.
Bio Fund Iv, L.p. Ah's most recent insider trade was on Aug 7, 2026, when they sold 40,000,000 shares at $0.00 per share.
Bio Fund Iv, L.p. Ah serves as Executive at Braveheart Bio, Inc. (BRVE). They have executed 3 insider transactions totaling $19.8M over their tenure at the company.
Bio Fund Iv, L.p. Ah holds the position of Executive at Braveheart Bio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Bio Fund Iv, L.p. Ah has shown a buying trading pattern, with $19.8M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Bio Fund Iv, L.p. Ah was on Aug 7, 2026, when they purchased $19.8M worth of BRVE shares. This transaction involved 1,100,000 shares at $18.00 per share.
Bio Fund Iv, L.p. Ah currently owns 10,232,420 shares of Braveheart Bio, Inc. (BRVE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bio Fund Iv, L.p. Ah's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bio Fund Iv, L.p. Ah has 3 Form 4 filings on record as an insider at Braveheart Bio, Inc..
Set alerts for Bio Fund Iv, L.p. Ah and 40,000+ other insiders.